Therapeutic implications and clinical manifestations of thymoquinone
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alam, M. | - |
dc.contributor.author | Hasan, G.M. | - |
dc.contributor.author | Ansari, M.M. | - |
dc.contributor.author | Sharma, R. | - |
dc.contributor.author | Yadav, D.K. | - |
dc.contributor.author | Hassan, M.I. | - |
dc.date.accessioned | 2022-06-17T04:40:04Z | - |
dc.date.available | 2022-06-17T04:40:04Z | - |
dc.date.created | 2022-05-24 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 0031-9422 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/84636 | - |
dc.description.abstract | Thymoquinone (TQ), a natural phytochemical predominantly found in Nigella sativa, has been investigated for its numerous health benefits. TQ showed anti-cancer, anti-oxidant, and anti-inflammatory properties, validated in various disease models. The anti-cancer potential of TQ is goverened by anti-proliferation, cell cycle arrest, apoptosis induction, ROS production, anti-metastasis and anti-angiogenesis, inhibition of cell migration and invasion action. Additionally, TQ exhibited antitumor activity via the modulation of multiple pathways and molecular targets, including Akt, ERK1/2, STAT3, and NF-κB. The present review highlighted the anticancer potential of TQ. We summarize the anti-cancer, anti-oxidant, and anti-inflammatory properties of TQ, focusing on its molecular targets and its promising action in cancer therapy. We further described the molecular mechanisms by which TQ prevents signaling pathways that mediate cancer progression, invasion, and metastasis. © 2022 Elsevier Ltd | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.relation.isPartOf | Phytochemistry | - |
dc.title | Therapeutic implications and clinical manifestations of thymoquinone | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000803742000002 | - |
dc.identifier.doi | 10.1016/j.phytochem.2022.113213 | - |
dc.identifier.bibliographicCitation | Phytochemistry, v.200 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85129102235 | - |
dc.citation.title | Phytochemistry | - |
dc.citation.volume | 200 | - |
dc.contributor.affiliatedAuthor | Yadav, D.K. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Anti-cancer | - |
dc.subject.keywordAuthor | Anti-inflammatory | - |
dc.subject.keywordAuthor | Anti-oxidant | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Cancer therapy | - |
dc.subject.keywordAuthor | Signaling pathways | - |
dc.subject.keywordAuthor | Thymoquinone | - |
dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMA | - |
dc.subject.keywordPlus | NIGELLA-SATIVA OIL | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | PROSTATE-CANCER CELLS | - |
dc.subject.keywordPlus | HUMAN HEPATIC CARCINOMA | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | INHIBITS PROLIFERATION | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Plant Sciences | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.